The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 28, 2021
Filed:
Jul. 19, 2018
Applicant:
Novo Nordisk A/s, Bagsvaerd, DK;
Inventors:
Christian Wenzel Tornoee, Lyngby, DK;
Anne Louise Bank Kodal, Koebenhavn N, DK;
Steffen Reedtz-Runge, Bikeroed, DK;
Lennart Lykke, Koebenhavn V, DK;
Assignee:
Novo Nordisk A/S, Bagsvaerd, DK;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07K 19/00 (2006.01); A61K 38/17 (2006.01); A61K 38/26 (2006.01); A61K 47/64 (2017.01); A61K 47/65 (2017.01); C07K 14/605 (2006.01); C07K 14/485 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
C07K 14/605 (2013.01); A61K 38/177 (2013.01); A61K 38/26 (2013.01); A61K 47/6425 (2017.08); A61K 47/65 (2017.08); C07K 14/485 (2013.01); A61K 38/00 (2013.01); C07K 2319/00 (2013.01); C07K 2319/32 (2013.01);
Abstract
The application discloses compounds useful in treatment of diabetes, weight loss and/or reduction of cardiovascular risks. The compounds are bi-functional and therefore suitable as a simple treatment for patients that may benefit from treatment with both a GLP-1 receptor agonist and a PCSK9 inhibitor.